(Q63595555)
Statements
Phase 1, Multicenter, Randomized, Placebo-Controlled, Triple-Blind, Single-Ascending Dose and Repeat-Dose Trial in Healthy Participants and Participants With Atopic Dermatitis (English)
0 references
29 November 2018
0 references
20 May 2020
0 references
128
0 references
18 year
0 references
65 year
0 references